Ajay K. Nooka, MD, MPH, FACP

Associate Professor
Department of Hematology and Medical Oncology
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Dr. Ajay Nooka received his medical degree from Andhra Medical College in India before relocating to the United States. He received a master’s in public health from The University of Texas School of Public Health in Houston, and then completed his internship and residency at the Northeastern Ohio University College of Medicine. He also pursued a fellowship in hematology and oncology at Emory University School of Medicine in Atlanta, Georgia where he also served as chief fellow before he joined the faculty. Dr. Nooka is currently an Associate Professor in the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University.

Board certified in hematology and medical oncology, Dr. Nooka primarily focuses on multiple myeloma treatment and research. He is involved in numerous professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology, and the American Society for Blood and Marrow Transplantation. 

Dr. Nooka’s interests as a clinical investigator focus on multiple myeloma and bone marrow transplant. His research interests include integrating genomic and clinical data on a uniform platform to risk-stratify myeloma, and to evaluate newer myeloma therapeutic strategies aimed at prolonging survival in myeloma patients. In addition to leading several investigator-initiated and industry-sponsored clinical trials, he is a recipient of several awards and grants including the Multiple Myeloma Research Foundation Accelerator Award and the International Myeloma Foundation Research Grants. He has published more than 200 articles and abstracts in peer-reviewed journals including The New England Journal of Medicine, Journal of Clinical Oncology, Blood, Leukemia, Lancet Oncology, and Cancer. In addition, he serves on the editorial board of the American Journal of Clinical Oncology and as an invited/ad hoc reviewer for several prestigious journals including Lancet Oncology, Journal of Clinical Oncology, Cancer, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation

Last modified: March 23, 2021